ArticleBiology direct2024

Phosphodiesterase type 5 inhibitor tadalafil reduces prostatic fibrosis via MiR-3126-3p/FGF9 axis in benign prostatic hyperplasia.

Tiewen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.